A Recessive Founder Mutation in Regulator of Telomere Elongation Helicase 1, , Underlies Severe Immunodeficiency and Features of Hoyeraal Hreidarsson Syndrome

English version České info

Dyskeratosis congenita (DC) is a heterogeneous inherited bone marrow failure and cancer predisposition syndrome in which germline mutations in telomere biology genes account for approximately one-half of known families. Hoyeraal Hreidarsson syndrome (HH) is a clinically severe variant of DC in which patients also have cerebellar hypoplasia and may present with severe immunodeficiency and enteropathy. We discovered a germline autosomal recessive mutation in RTEL1, a helicase with critical telomeric functions, in two unrelated families of Ashkenazi Jewish (AJ) ancestry. The affected individuals in these families are homozygous for the same mutation, R1264H, which affects three isoforms of RTEL1. Each parent was a heterozygous carrier of one mutant allele. Patient-derived cell lines revealed evidence of telomere dysfunction, including significantly decreased telomere length, telomere length heterogeneity, and the presence of extra-chromosomal circular telomeric DNA. In addition, RTEL1 mutant cells exhibited enhanced sensitivity to the interstrand cross-linking agent mitomycin C. The molecular data and the patterns of inheritance are consistent with a hypomorphic mutation in RTEL1 as the underlying basis of the clinical and cellular phenotypes. This study further implicates RTEL1 in the etiology of DC/HH and immunodeficiency, and identifies the first known homozygous autosomal recessive disease-associated mutation in RTEL1.

Vyšlo v časopise: A Recessive Founder Mutation in Regulator of Telomere Elongation Helicase 1, , Underlies Severe Immunodeficiency and Features of Hoyeraal Hreidarsson Syndrome. PLoS Genet 9(8): e32767. doi:10.1371/journal.pgen.1003695
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1003695

Souhrn

Zdroje

1. SavageSA, BertuchAA (2010) The genetics and clinical manifestations of telomere biology disorders. Genet Med 12: 753–764.

2. AlterBP, GiriN, SavageSA, PetersJA, LoudJT, et al. (2010) Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study. Br J Haematol 150: 179–188.

3. AlterBP, RosenbergPS, GiriN, BaerlocherGM, LansdorpPM, et al. (2012) Telomere length is associated with disease severity and declines with age in dyskeratosis congenita. Haematologica 97: 353–359.

4. NelsonND, BertuchAA (2012) Dyskeratosis congenita as a disorder of telomere maintenance. Mutat Res 730: 43–51.

5. WalneA, BhagatT, KirwanM, GitauxC, DesguerreI, et al. (2012) Mutations in the telomere capping complex in bone marrow failure and related syndromes. Haematologica 98 (3) 334–8.

6. BallewBJ, YeagerM, JacobsK, GiriN, BolandJ, et al. (2013) Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita. Hum Genet 132: 473–480.

7. WalneAJ, VulliamyT, KirwanM, PlagnolV, DokalI (2013) Constitutional Mutations in RTEL1 Cause Severe Dyskeratosis Congenita. Am J Hum Genet 92 (3) 448–53.

8. Le GuenT, JullienL, TouzotF, SchertzerM, GaillardL, et al. (2013) Human RTEL1 deficiency causes Hoyeraal-Hreidarsson syndrome with short telomeres and genome instability. Hum Mol Genet 22 (16) 3239–49.

9. JyonouchiS, ForbesL, RuchelliE, SullivanKE (2011) Dyskeratosis congenita: a combined immunodeficiency with broad clinical spectrum–a single-center pediatric experience. Pediatr Allergy Immunol 22: 313–319.

10. ShearerWT, RosenblattHM, GelmanRS, OyomopitoR, PlaegerS, et al. (2003) Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol 112: 973–980.

11. KellerRB, GagneKE, UsmaniGN, AsdourianGK, WilliamsDA, et al. (2012) CTC1 Mutations in a patient with dyskeratosis congenita. Pediatr Blood Cancer 59: 311–314.

12. ConsortiumGP (2010) A map of human genome variation from population-scale sequencing. Nature 467: 1061–1073.

13. LovejoyCA, LiW, ReisenweberS, ThongthipS, BrunoJ, et al. (2012) Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway. PLoS genetics 8: e1002772.

14. VannierJB, Pavicic-KaltenbrunnerV, PetalcorinMI, DingH, BoultonSJ (2012) RTEL1 dismantles T loops and counteracts telomeric G4-DNA to maintain telomere integrity. Cell 149: 795–806.

15. ZellingerB, AkimchevaS, PuizinaJ, SchiratoM, RihaK (2007) Ku suppresses formation of telomeric circles and alternative telomere lengthening in Arabidopsis. Molecular Cell 27: 163–169.

16. BarberLJ, YoudsJL, WardJD, McIlwraithMJ, O'NeilNJ, et al. (2008) RTEL1 maintains genomic stability by suppressing homologous recombination. Cell 135: 261–271.

17. VilleneuveAM (2008) Ensuring an exit strategy: RTEL1 restricts rogue recombination. Cell 135: 213–215.

18. CesareAJ, GriffithJD (2004) Telomeric DNA in ALT cells is characterized by free telomeric circles and heterogeneous t-loops. Mol Cell Biol 24: 9948–9957.

19. DingH, SchertzerM, WuX, GertsensteinM, SeligS, et al. (2004) Regulation of murine telomere length by Rtel: an essential gene encoding a helicase-like protein. Cell 117: 873–886.

20. ChistiakovDA (2010) Ligase IV syndrome. Adv Exp Med Biol 685: 175–185.

21. ShimamuraA, AlterBP (2010) Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev 24: 101–122.

22. DeshaiesRJ, JoazeiroCA (2009) RING domain E3 ubiquitin ligases. Annu Rev Biochem 78: 399–434.

23. WrenschM, JenkinsRB, ChangJS, YehRF, XiaoY, et al. (2009) Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 41: 905–908.

24. SheteS, HoskingFJ, RobertsonLB, DobbinsSE, SansonM, et al. (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41: 899–904.

25. EganKM, ThompsonRC, NaborsLB, OlsonJJ, BratDJ, et al. (2011) Cancer susceptibility variants and the risk of adult glioma in a US case-control study. J Neurooncol 104: 535–542.

26. BaerlocherGM, VultoI, de JongG, LansdorpPM (2006) Flow cytometry and FISH to measure the average length of telomeres (flow FISH). Nat Protoc 1: 2365–2376.

27. DePristoMA, BanksE, PoplinR, GarimellaKV, MaguireJR, et al. (2011) A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43: 491–498.

28. GlusmanG, CaballeroJ, MauldinDE, HoodL, RoachJC (2011) Kaviar: an accessible system for testing SNV novelty. Bioinformatics 27: 3216–3217.

29. SherryST, WardMH, KholodovM, BakerJ, PhanL, et al. (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29: 308–311.

30. TewheyR, WarnerJB, NakanoM, LibbyB, MedkovaM, et al. (2009) Microdroplet-based PCR enrichment for large-scale targeted sequencing. Nat Biotechnol 27: 1025–1031.

31. AdzhubeiIA, SchmidtS, PeshkinL, RamenskyVE, GerasimovaA, et al. (2010) A method and server for predicting damaging missense mutations. Nat Methods 7: 248–249.

32. KumarP, HenikoffS, NgPC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4: 1073–1081.

33. Gonzalez-PerezA, Lopez-BigasN (2011) Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. Am J Hum Genet 88: 440–449.

34. NotredameC, HigginsDG, HeringaJ (2000) T-Coffee: A novel method for fast and accurate multiple sequence alignment. J Mol Biol 302: 205–217.

35. AttwoollCL, AkpinarM, PetriniJH (2009) The mre11 complex and the response to dysfunctional telomeres. Mol Cell Biol 29: 5540–5551.

36. Munoz-JordanJL, CrossGA, de LangeT, GriffithJD (2001) t-loops at trypanosome telomeres. EMBO J 20: 579–588.

37. ZellingerB, AkimchevaS, PuizinaJ, SchiratoM, RihaK (2007) Ku suppresses formation of telomeric circles and alternative telomere lengthening in Arabidopsis. Mol Cell 27: 163–169.

38. StrackerTH, WilliamsBR, DerianoL, TheunissenJW, AdelmanCA, et al. (2009) Artemis and nonhomologous end joining-independent influence of DNA-dependent protein kinase catalytic subunit on chromosome stability. Molecular and Cellular Biology 29: 503–514.

39. CelliGB, de LangeT (2005) DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion. Nat Cell Biol 7: 712–718.